 |
 |

COMMENTS & OPINIONS
QTc Prolongation Among Hospitalized Patients Receiving Methadone
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
We read with interest the study by Ehret and colleagues1 suggesting that clinically significant QTc interval prolongation (>500 milliseconds) occurred in over 16% of hospitalized patients receiving methadone. In practice, this probably overestimates the expected frequency of QTc prolongation with methadone use, given the authors exclusion criteria, but nonetheless suggests that considerable QTc prolongation with methadone use is probably not a rare phenomena.
The authors observed a modest correlation between methadone dose and the absolute QTc interval (r = +0.2; P<.01). Although they suggest that a dose-dependent effect of methadone has not been previously described in the hospital setting, we found a similar correlation between methadone dose and QTc among methadone-treated patients hospitalized with TdP (r = +0.51; P = .03).2 Variation in the strength of this correlation may be related to the fact that only 3.6% of the cohort in the study by Ehret et al1 experienced documented TdP . . . [Full Text of this Article] AUTHOR INFORMATION
John Schmittner, MD;
Mori J. Krantz, MD
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLES
Drug-Induced Long QT Syndrome in Injection Drug Users Receiving Methadone: High Frequency in Hospitalized Patients and Risk Factors
Georg B. Ehret, Cathy Voide, Marianne Gex-Fabry, Jocelyne Chabert, Dipen Shah, Barbara Broers, Valérie Piguet, Thierry Musset, Jean-Michel Gaspoz, Arnaud Perrier, Pierre Dayer, and Jules A. Desmeules
Arch Intern Med. 2006;166(12):1280-1287.
ABSTRACT
| FULL TEXT
Treating Opioid Dependence: Growing Implications for Primary Care
Mori J. Krantz and Philip S. Mehler
Arch Intern Med. 2004;164(3):277-288.
ABSTRACT
| FULL TEXT
|